Gene · 23607
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,872
Download this page as JSON| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| R01AG061093 | Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimer's pathology and cerebrovascular disease | 1 | 2024 |
| R01AG066524 | Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience | 1 | 2024 |
| R01AG069765 | Digital Detection of Dementia Studies (D cubed Studies). | 1 | 2024 |
| R01AI109022 | Mechanisms of Nipah virus fusion and entry | 1 | 2024 |
| R01AI153209 | An Informed Approach to Live Attenuated Vaccines against Encephalitis Alphaviruses | 1 | 2024 |
| R01CA193297 | PAF-Remodeled DREAM Complex in Cancer and Regeneration | 1 | 2024 |
| R01DK051265 | Mechanisms of EGFR Activation and Signaling in Kidney Disease | 1 | 2024 |
| R01DK082753 | Elucidating IgA nephropathy through Genetic Studies of IgA1 Glycosylation | 1 | 2024 |
| R01DK088826 | Biological Mechanism of INF2-mediated FSGS | 1 | 2024 |
| R01DK104264 | Neonatal Fc Receptor (FcRn) Trafficking of Immune Complexes to the Lysosome as a Driver of Glomerulonephritis | 1 | 2024 |
| R01DK125546 | Myosin-2 function in the enterocyte terminal web | 1 | 2024 |
| R01EB015611 | Solar-Eclipse Computational Tools for Imaging Genetics | 1 | 2024 |
| R01EY022310 | International Advancing genomics through the AMD Genomics Consortium (IAMDGC) | 1 | 2024 |
| R01GM067945 | New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin Biology | 1 | 2024 |
| R01GM140287 | Haplotype-aware models of gene and isoform expression with application to genetic studies of disease in diverse populations | 1 | 2024 |
| R01HG011138 | Advancing Multi-Omics and Electronic Health Records Computational Methodologies | 1 | 2024 |
| R01MD014726 | APOL1 Nephropathy: Linking Genetics and Mechanisms | 1 | 2024 |
| R01MH121079 | Computational examination of RDoC threat and reward constructs in a representative, predominantly low-income, longitudinal sample at increased risk for internalizing disorders (Admin Supplement) | 1 | 2024 |
| R01NS089076 | Epigenetic Pathology and Therapy in Huntington's Disease | 1 | 2024 |
| R15AG083618 | Convolutional Neural Network for Disease Prediction, Biomarker Discovery, and Validation in Alzheimer's Disease | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/grants?page=18